{"transactions":[{"id":1219628,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-03-06T18:48:35.000Z","date":"2025-03-04","kind":"exercise","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":24.03,"expiration_date":"2028-04-04","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001062993-25-004776","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299325004776/form4.xml","form_type":"4"}},{"id":1219627,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-03-06T18:48:35.000Z","date":"2025-03-06","kind":"sale","planned":false,"acquired":false,"shares":26067,"price":28.5014,"value":742945.9938,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.50 to $28.58, inclusive."}],"balance_after":108137,"source":{"system":"sec-edgar","filing":"0001062993-25-004776","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299325004776/form4.xml","form_type":"4"}},{"id":1219626,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-03-06T18:48:35.000Z","date":"2025-03-05","kind":"sale","planned":false,"acquired":false,"shares":20000,"price":28.0264,"value":560528.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.18, inclusive."}],"balance_after":134204,"source":{"system":"sec-edgar","filing":"0001062993-25-004776","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299325004776/form4.xml","form_type":"4"}},{"id":1219625,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-03-06T18:48:35.000Z","date":"2025-03-04","kind":"sale","planned":false,"acquired":false,"shares":40000,"price":28.079,"value":1123160.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4."}],"balance_after":154204,"source":{"system":"sec-edgar","filing":"0001062993-25-004776","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299325004776/form4.xml","form_type":"4"}},{"id":1219624,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-03-06T18:48:35.000Z","date":"2025-03-04","kind":"exercise","planned":false,"acquired":true,"shares":40000,"price":24.03,"value":961200.0,"ownership":{"direct":true},"balance_after":194204,"source":{"system":"sec-edgar","filing":"0001062993-25-004776","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299325004776/form4.xml","form_type":"4"}},{"id":1271758,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-02-12T16:09:38.000Z","date":"2025-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":25149,"price":30.52,"value":767547.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs."}],"balance_after":154204,"source":{"system":"sec-edgar","filing":"0001062993-25-002175","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299325002175/form4.xml","form_type":"4"}},{"id":1271757,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-02-12T16:09:38.000Z","date":"2025-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":9826,"price":30.52,"value":299889.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs."}],"balance_after":179353,"source":{"system":"sec-edgar","filing":"0001062993-25-002175","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299325002175/form4.xml","form_type":"4"}},{"id":1271756,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-02-12T16:09:38.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":29030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Effective February 10, 2025, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 29,030 performance share units (\"PSUs\") granted in the Issuer's three prior fiscal years."}],"balance_after":189179,"source":{"system":"sec-edgar","filing":"0001062993-25-002175","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299325002175/form4.xml","form_type":"4"}},{"id":1271755,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-02-12T16:09:38.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":40965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2026, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock."}],"balance_after":160149,"source":{"system":"sec-edgar","filing":"0001062993-25-002175","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299325002175/form4.xml","form_type":"4"}},{"id":1303505,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-01-14T16:12:27.000Z","date":"2025-01-10","kind":"exercise","planned":true,"acquired":false,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":21.34,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001062993-25-000761","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299325000761/form4.xml","form_type":"4"}},{"id":1303504,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-01-14T16:12:27.000Z","date":"2025-01-10","kind":"sale","planned":true,"acquired":false,"shares":6100,"price":33.6427,"value":205220.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.42 to $33.41, inclusive."}],"balance_after":119184,"source":{"system":"sec-edgar","filing":"0001062993-25-000761","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299325000761/form4.xml","form_type":"4"}},{"id":1303503,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-01-14T16:12:27.000Z","date":"2025-01-10","kind":"sale","planned":true,"acquired":false,"shares":21400,"price":32.8695,"value":703407.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.43 to $33.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":125284,"source":{"system":"sec-edgar","filing":"0001062993-25-000761","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299325000761/form4.xml","form_type":"4"}},{"id":1303502,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-01-14T16:12:27.000Z","date":"2025-01-10","kind":"exercise","planned":true,"acquired":true,"shares":27500,"price":21.34,"value":586850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2024."}],"balance_after":146684,"source":{"system":"sec-edgar","filing":"0001062993-25-000761","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299325000761/form4.xml","form_type":"4"}},{"id":1412754,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-09-06T17:52:56.000Z","date":"2024-09-06","kind":"sale","planned":false,"acquired":false,"shares":977,"price":37.4556,"value":36594.1212,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.455 to $37.4592, inclusive."}],"balance_after":119184,"source":{"system":"sec-edgar","filing":"0001062993-24-016277","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299324016277/form4.xml","form_type":"4"}},{"id":1412753,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-09-06T17:52:56.000Z","date":"2024-09-05","kind":"sale","planned":false,"acquired":false,"shares":2400,"price":39.1421,"value":93941.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.01 to $39.20, inclusive."}],"balance_after":120161,"source":{"system":"sec-edgar","filing":"0001062993-24-016277","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299324016277/form4.xml","form_type":"4"}},{"id":1412752,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-09-06T17:52:56.000Z","date":"2024-09-05","kind":"sale","planned":false,"acquired":false,"shares":16848,"price":38.18,"value":643256.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.00 to $38.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4."}],"balance_after":122561,"source":{"system":"sec-edgar","filing":"0001062993-24-016277","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299324016277/form4.xml","form_type":"4"}},{"id":1490106,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-06-05T16:06:13.000Z","date":"2024-06-03","kind":"sale","planned":true,"acquired":false,"shares":700,"price":33.22,"value":23254.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.19 to $33.31, inclusive."}],"balance_after":139409,"source":{"system":"sec-edgar","filing":"0001062993-24-011979","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299324011979/form4.xml","form_type":"4"}},{"id":1490105,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-06-05T16:06:13.000Z","date":"2024-06-03","kind":"sale","planned":true,"acquired":false,"shares":24300,"price":32.5484,"value":790926.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.18 to $33.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":140109,"source":{"system":"sec-edgar","filing":"0001062993-24-011979","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299324011979/form4.xml","form_type":"4"}},{"id":1643234,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-02-14T16:14:11.000Z","date":"2024-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":10610,"price":33.7,"value":357557.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs."}],"balance_after":164409,"source":{"system":"sec-edgar","filing":"0001062993-24-003167","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299324003167/form4.xml","form_type":"4"}},{"id":1643233,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-02-14T16:14:11.000Z","date":"2024-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":21146,"price":33.7,"value":712620.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs."}],"balance_after":175019,"source":{"system":"sec-edgar","filing":"0001062993-24-003167","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299324003167/form4.xml","form_type":"4"}},{"id":1643232,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-02-14T16:14:11.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":33247,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Effective February 12, 2024, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 33,247 performance share units (\"PSUs\") granted in the Issuer's three prior fiscal years."}],"balance_after":196165,"source":{"system":"sec-edgar","filing":"0001062993-24-003167","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299324003167/form4.xml","form_type":"4"}},{"id":1643231,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-02-14T16:14:11.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":43400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2025, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock."}],"balance_after":162918,"source":{"system":"sec-edgar","filing":"0001062993-24-003167","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299324003167/form4.xml","form_type":"4"}},{"id":1727708,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Stock Option (Right to Purchase)","published_at":"2023-11-29T16:32:50.000Z","date":"2023-11-27","kind":"exercise","planned":true,"acquired":false,"shares":25600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":15.9,"expiration_date":"2029-01-25","underlying":"Common Stock","underlying_shares":25600},"source":{"system":"sec-edgar","filing":"0001062993-23-021604","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299323021604/form4.xml","form_type":"4"}},{"id":1727707,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-11-29T16:32:50.000Z","date":"2023-11-27","kind":"sale","planned":true,"acquired":false,"shares":25600,"price":25.7818,"value":660014.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.76 to $25.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":119518,"source":{"system":"sec-edgar","filing":"0001062993-23-021604","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299323021604/form4.xml","form_type":"4"}},{"id":1727706,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-11-29T16:32:50.000Z","date":"2023-11-27","kind":"exercise","planned":true,"acquired":true,"shares":25600,"price":15.9,"value":407040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2023."}],"balance_after":145118,"source":{"system":"sec-edgar","filing":"0001062993-23-021604","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299323021604/form4.xml","form_type":"4"}},{"id":1842741,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-06-28T16:08:20.000Z","date":"2023-06-26","kind":"sale","planned":true,"acquired":false,"shares":1363,"price":22.5349,"value":30715.0687,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.39 to $22.59, inclusive."}],"balance_after":119518,"source":{"system":"sec-edgar","filing":"0001062993-23-014095","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299323014095/form4.xml","form_type":"4"}},{"id":1842740,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-06-28T16:08:20.000Z","date":"2023-06-26","kind":"sale","planned":true,"acquired":false,"shares":16621,"price":21.6544,"value":359917.7824,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.26 to $22.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":120881,"source":{"system":"sec-edgar","filing":"0001062993-23-014095","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299323014095/form4.xml","form_type":"4"}},{"id":2016587,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-02-14T17:18:41.000Z","date":"2023-02-13","kind":"sale","acquired":false,"shares":21811,"price":26.88,"value":586279.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 28, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.485 to $27.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6)."}],"balance_after":137502,"source":{"system":"sec-edgar","filing":"0001062993-23-003479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299323003479/form4.xml","form_type":"4"}},{"id":2016586,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-02-14T17:18:41.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":7755,"price":26.75,"value":207446.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units."}],"balance_after":159313,"source":{"system":"sec-edgar","filing":"0001062993-23-003479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299323003479/form4.xml","form_type":"4"}},{"id":2016585,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-02-14T17:18:41.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":16291,"price":26.75,"value":435784.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":167068,"source":{"system":"sec-edgar","filing":"0001062993-23-003479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299323003479/form4.xml","form_type":"4"}},{"id":2016584,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-02-14T17:18:41.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":25739,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Effective February 10, 2023, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 25,739 performance share units granted in the issuer's three prior fiscal years."}],"balance_after":183359,"source":{"system":"sec-edgar","filing":"0001062993-23-003479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299323003479/form4.xml","form_type":"4"}},{"id":2016583,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-02-14T17:18:41.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":48125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2024, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":157620,"source":{"system":"sec-edgar","filing":"0001062993-23-003479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299323003479/form4.xml","form_type":"4"}},{"id":2157414,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-09-16T16:22:04.000Z","date":"2022-09-15","kind":"sale","acquired":false,"shares":38589,"price":18.07,"value":697303.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2022 and amended on August 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.91 to $18.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":109495,"source":{"system":"sec-edgar","filing":"0001062993-22-019618","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299322019618/form4.xml","form_type":"4"}},{"id":2185689,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-08-15T16:34:40.000Z","date":"2022-08-11","kind":"sale","acquired":false,"shares":300,"price":20.01,"value":6003.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":148084,"source":{"system":"sec-edgar","filing":"0001062993-22-017994","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299322017994/form4.xml","form_type":"4"}},{"id":2324711,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-03-18T16:03:10.000Z","date":"2022-03-16","kind":"tax_withholding","acquired":false,"shares":734,"price":18.99,"value":13938.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":148384,"source":{"system":"sec-edgar","filing":"0001062993-22-008131","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299322008131/form4.xml","form_type":"4"}},{"id":2398223,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-02-14T18:37:01.000Z","date":"2022-02-10","kind":"tax_withholding","acquired":false,"shares":4212,"price":17.63,"value":74257.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units."}],"balance_after":149118,"source":{"system":"sec-edgar","filing":"0001062993-22-004319","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299322004319/form4.xml","form_type":"4"}},{"id":2398222,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-02-14T18:37:01.000Z","date":"2022-02-10","kind":"tax_withholding","acquired":false,"shares":6967,"price":17.63,"value":122828.21,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":153330,"source":{"system":"sec-edgar","filing":"0001062993-22-004319","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299322004319/form4.xml","form_type":"4"}},{"id":2398221,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-02-14T18:37:01.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":14341,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 10, 2022, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 14,341 performance share units granted in the issuer's three prior fiscal years."}],"balance_after":160297,"source":{"system":"sec-edgar","filing":"0001062993-22-004319","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299322004319/form4.xml","form_type":"4"}},{"id":2398220,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-02-14T18:37:01.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":56700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2023, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":145956,"source":{"system":"sec-edgar","filing":"0001062993-22-004319","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299322004319/form4.xml","form_type":"4"}},{"id":2564208,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-09-20T16:03:04.000Z","date":"2021-09-16","kind":"tax_withholding","acquired":false,"shares":734,"price":19.67,"value":14437.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":89256,"source":{"system":"sec-edgar","filing":"0001879789-21-000003","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000187978921000003/edgar.xml","form_type":"4"}},{"id":2716532,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-05-12T16:06:43.000Z","date":"2021-05-10","kind":"sale","acquired":false,"shares":7000,"price":22.77,"value":159390.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021."}],"balance_after":89990,"source":{"system":"sec-edgar","filing":"0001192482-21-000419","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000119248221000419/edgar.xml","form_type":"4"}},{"id":2779459,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-03-18T16:07:47.000Z","date":"2021-03-16","kind":"tax_withholding","acquired":false,"shares":734,"price":24.69,"value":18122.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":96990,"source":{"system":"sec-edgar","filing":"0001192482-21-000251","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000119248221000251/edgar.xml","form_type":"4"}},{"id":2863564,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-02-12T16:16:25.000Z","date":"2021-02-10","kind":"tax_withholding","acquired":false,"shares":3695,"price":25.95,"value":95885.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":97724,"source":{"system":"sec-edgar","filing":"0001192482-21-000150","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000119248221000150/edgar.xml","form_type":"4"}},{"id":2863563,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-02-12T16:16:25.000Z","date":"2021-02-10","kind":"tax_withholding","acquired":false,"shares":2163,"price":25.95,"value":56129.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of performance stock units."}],"balance_after":101419,"source":{"system":"sec-edgar","filing":"0001192482-21-000150","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000119248221000150/edgar.xml","form_type":"4"}},{"id":2899392,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-01-22T16:05:24.000Z","date":"2021-01-20","kind":"sale","acquired":false,"shares":6081,"price":24.45,"value":148680.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":103582,"source":{"system":"sec-edgar","filing":"0001192482-21-000094","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000119248221000094/edgar.xml","form_type":"4/A","original_submission_date":"2021-01-21"}},{"id":2899391,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-01-22T16:05:24.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":6772,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 19, 2021, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to 6,772 performance share units granted in two prior years."}],"balance_after":109663,"source":{"system":"sec-edgar","filing":"0001192482-21-000094","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000119248221000094/edgar.xml","form_type":"4/A","original_submission_date":"2021-01-21"}},{"id":2899390,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-01-22T16:05:24.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":45360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2022, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":102891,"source":{"system":"sec-edgar","filing":"0001192482-21-000094","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000119248221000094/edgar.xml","form_type":"4/A","original_submission_date":"2021-01-21"}},{"id":2900857,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Stock Option (Right to Purchase)","published_at":"2021-01-21T16:29:48.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":129600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2022, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer."}],"balance_after":129600,"derivative":{"exercise_price":24.06,"expiration_date":"2031-01-19","underlying":"Common Stock","underlying_shares":129600},"source":{"system":"sec-edgar","filing":"0001192482-21-000085","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000119248221000085/edgar.xml","form_type":"4"}},{"id":2900856,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-01-21T16:29:48.000Z","date":"2021-01-20","kind":"sale","acquired":false,"shares":6081,"price":24.45,"value":148680.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":103582,"source":{"system":"sec-edgar","filing":"0001192482-21-000085","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000119248221000085/edgar.xml","form_type":"4"}},{"id":2900855,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-01-21T16:29:48.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":6772,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 19, 2021, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to 6,772 performance share units granted in two prior years."}],"balance_after":109663,"source":{"system":"sec-edgar","filing":"0001192482-21-000085","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000119248221000085/edgar.xml","form_type":"4"}},{"id":2900854,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-01-21T16:29:48.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":45360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2022, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":102891,"source":{"system":"sec-edgar","filing":"0001192482-21-000085","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000119248221000085/edgar.xml","form_type":"4"}},{"id":3005371,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-10-16T16:07:43.000Z","date":"2020-10-15","kind":"sale","acquired":false,"shares":7060,"price":20.82,"value":146989.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2020 and modified on September 15, 2020."}],"balance_after":57531,"source":{"system":"sec-edgar","filing":"0001192482-20-000777","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000119248220000777/edgar.xml","form_type":"4"}},{"id":3027093,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-09-18T16:17:07.000Z","date":"2020-09-16","kind":"tax_withholding","acquired":false,"shares":734,"price":19.33,"value":14188.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":64591,"source":{"system":"sec-edgar","filing":"0001192482-20-000703","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000119248220000703/edgar.xml","form_type":"4"}},{"id":3203053,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-03-18T16:16:06.000Z","date":"2020-03-16","kind":"tax_withholding","acquired":false,"shares":734,"price":15.41,"value":11310.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":65325,"source":{"system":"sec-edgar","filing":"0001192482-20-000240","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000119248220000240/edgar.xml","form_type":"4"}},{"id":3277226,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-02-12T16:25:26.000Z","date":"2020-02-10","kind":"tax_withholding","acquired":false,"shares":2085,"price":21.62,"value":45077.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":66059,"source":{"system":"sec-edgar","filing":"0001192482-20-000149","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000119248220000149/edgar.xml","form_type":"4"}},{"id":3284694,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-02-07T16:11:02.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2021, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer."}],"balance_after":27500,"derivative":{"exercise_price":21.34,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001192482-20-000138","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000119248220000138/edgar.xml","form_type":"4"}},{"id":3284693,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-02-07T16:11:02.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":24750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2021, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":68144,"source":{"system":"sec-edgar","filing":"0001192482-20-000138","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000119248220000138/edgar.xml","form_type":"4"}},{"id":3411007,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-09-18T16:06:16.000Z","date":"2019-09-16","kind":"tax_withholding","acquired":false,"shares":736,"price":12.44,"value":9155.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":43394,"source":{"system":"sec-edgar","filing":"0001192482-19-000360","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000119248219000360/edgar.xml","form_type":"4"}},{"id":3587290,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-03-19T17:41:24.000Z","date":"2019-03-15","kind":"tax_withholding","acquired":false,"shares":1470,"price":16.98,"value":24960.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":44130,"source":{"system":"sec-edgar","filing":"0001192482-19-000167","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000119248219000167/edgar.xml","form_type":"4"}},{"id":3683953,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Stock Option (Right to Purchase)","published_at":"2019-01-29T16:37:38.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":25600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2020, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer."}],"balance_after":25600,"derivative":{"exercise_price":15.9,"expiration_date":"2029-01-25","underlying":"Common Stock","underlying_shares":25600},"source":{"system":"sec-edgar","filing":"0001192482-19-000055","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000119248219000055/edgar.xml","form_type":"4"}},{"id":3683952,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2019-01-29T16:37:38.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":25600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2020, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":45600,"source":{"system":"sec-edgar","filing":"0001192482-19-000055","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000119248219000055/edgar.xml","form_type":"4"}},{"id":3968534,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Stock Option (Right to Purchase)","published_at":"2018-04-05T17:00:37.000Z","date":"2018-04-04","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the option vests and becomes exercisable on March 16, 2019, and the balance vests in equal monthly installments (rounded up to the nearest whole share of common stock) over the following three year period, subject to the reporting person's continued service with the issuer."}],"balance_after":40000,"derivative":{"exercise_price":24.03,"expiration_date":"2028-04-04","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001192482-18-000154","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000119248218000154/edgar.xml","form_type":"4"}},{"id":3968533,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2018-04-05T17:00:37.000Z","date":"2018-04-04","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on March 16, 2019, and the balance of the restricted stock units vest in equal installments every six months (in each case, rounded up to the nearest whole share of common stock) over the following three year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001192482-18-000154","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000119248218000154/edgar.xml","form_type":"4"}}]}